The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Implantable Venous Port Catheter in Cancer Patients

Indications, placement technique, and complication management for totally implantable venous access

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Implantable Venous Port Catheter in Cancer Patients?

An implantable venous port consists of a subcutaneous reservoir connected to a catheter whose tip rests in the cavoatrial junction. Devices remain functional for years, allow ambulatory use, and reduce peripheral vein damage compared with repeated peripheral access.

Indications include chemotherapy regimens beyond several months, vesicant agents, parenteral nutrition, frequent transfusion, and difficult peripheral access. Contraindications encompass active bacteremia, severe coagulopathy, and extensive central venous stenosis. Placement is done under image guidance using ultrasound for venous puncture and fluoroscopy for catheter tip confirmation.

Complications include catheter-related bloodstream infection, catheter-associated thrombosis, mechanical malfunction with fibrin sheath, and rare pneumothorax or arterial injury. Management combines blood cultures with concomitant peripheral and port draws, anticoagulation for thrombosis, and removal in selected scenarios such as fungemia, persistent infection, or definitive end of treatment.

Symptoms

Need for long-term chemotherapy access
Difficulty with peripheral venous access
Vesicant chemotherapy planning
Parenteral nutrition requirement
Frequent blood sampling need

Risk Factors

Solid tumor or hematologic malignancy
Planned multi-month chemotherapy
Prior chemotherapy with venous damage
Coagulopathy or thrombocytopenia
Local skin or soft tissue infection

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When long-term chemotherapy is planned
  • When fever or chills suggest catheter infection
  • When port site shows redness or swelling
  • When difficult flushing or aspiration appears
  • When port is no longer needed after end of treatment

Treatment Methods

01
Pre-procedural laboratory and coagulation review
02
Ultrasound-guided venous puncture
03
Fluoroscopic catheter tip confirmation
04
Sterile technique and post-procedural chest x-ray
05
Periodic flushing schedule
06
Blood cultures from port and peripheral site for suspected infection
07
Removal at end of treatment or for refractory complications

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.